Newsroom

Newsroom

Press Releases

Date Title and Summary Additional Formats
August 31, 2021
Nuwellis Inc. to Speak at Upcoming Investor Conferences
EDEN PRAIRIE, Minn. , Aug. 31, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, announced today that Nestor Jaramillo Jr ., Chief Executive officer, and George Montague , Chief Financial Officer, are
August 24, 2021
Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , Aug. 24, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective August 18, 2021 , the independent directors approved four equity awards under Nuwellis’ 2021 Inducement Plan, as material inducement to four individuals entering into employment
August 10, 2021
Nuwellis, Inc. Announces 35 Percent Increase in Revenue for Second Quarter 2021 Over Previous Year and Provides Company Update
EDEN PRAIRIE, Minn. , Aug. 10, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the second quarter ended June 30, 2021 , which included the following highlights: Reported record quarterly revenue of $2.5 million , a 35 percent increase compared to the prior
August 5, 2021
Nuwellis to Advance Treatment of Critically-Ill Children and Babies Under $1.7 Million NIH Grant
Funds will Support Creation of Life-Saving Pediatric Fluid Management Product EDEN PRAIRIE, Minn. , Aug. 05, 2021 (GLOBE NEWSWIRE) -- Critically-ill children and babies with kidney failure or who are dependent on artificial kidney support currently do not have enough therapeutic options.
July 27, 2021
Nuwellis, Inc. To Announce Second Quarter 2021 Financial Results on August 10, 2021
EDEN PRAIRIE, Minn. , July 27, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), announced today that its second quarter 2021 financial results will be released on Tuesday, August 10, 2021. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss
July 13, 2021
American Medical Association Issues New CPT Code for Nuwellis’ Aquadex Ultrafiltration
The newly classified code expands access to life-saving, novel fluid removal technology EDEN PRAIRIE, Minn. , July 13, 2021 (GLOBE NEWSWIRE) -- In an effort to increase the availability of life-saving ultrafiltration therapy to people experiencing fluid overload, the American Medical Association
July 6, 2021
Nuwellis Inc. to Participate at the 2021 Ladenburg Thalmann Healthcare Conference
EDEN PRAIRIE, Minn. , July 06, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, today announced that, Nestor Jaramillo , Chief Executive officer, and George Montague , Chief Financial Officer, are scheduled
June 24, 2021
Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , June 24, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective June 22, 2021 , the independent directors approved four equity awards under Nuwellis’ 2021 Inducement Plan, as material inducement to four individuals entering into employment with
June 22, 2021
Nuwellis Announces New Appointments to Leadership Team
George Montague to serve as Chief Financial Officer and Neil P. Ayotte, to serve as General Counsel and Chief Compliance Officer EDEN PRAIRIE, Minn. , June 22, 2021 (GLOBE NEWSWIRE) -- Continuing its dynamic growth in support of its commitment to expanding access to life-saving ultrafiltration
June 1, 2021
Nationwide Access to Ultrafiltration Therapy Possible with Nuwellis and Premier, Inc. Collaboration
Leading group purchasing organization will utilize relationships to consolidate costs and expand nationwide reach of the Aquadex SmartFlow® System EDEN PRAIRIE, Minn. , June 01, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), formerly CHF Solutions, Inc.
Displaying 11 - 20 of 43

Upcoming Events

More events are coming soon.
jump